First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...
NeuroSafe preserves the nerves running through the prostate’s outer layers, which are thought to be responsible for producing ...
The NeuroSafe technique focuses on preserving the delicate nerves that run through the outer layers of the prostate, believed ...
Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...
Non–AR-driven prostate cancer has been associated with aggressive behavior and poor prognosis, including in some cases histologic transformation to a poorly differentiated neuroendocrine prostate ...
EPIDEMIOLOGIC studies on modifiable factors after a prostate cancer (PCa) diagnosis remain inconclusive. Postdiagnosis ...
Groth, MD, Department of Pathology and Laboratory Medicine ... This is particularly difficult in prostate cancer, where diagnoses, prognosis, and appropriate management strategies can vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback